Hologic's breast-biopsy device gets CE Mark approval

11/6/2008 | HealthImaging.com

Hologic has secured European CE Mark approval for its Celero vacuum-assisted core biopsy device. The product is designed to reach lesions in the axilla, as well as other parts of the breast, during ultrasound imaging. Hologic also obtained clearance in Europe for other products, including the CeleroMark and CeleroMark-2S biopsy site identifiers.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA